Analysts upgrade Elevance, Centene shares as Medicaid margins expected to recover [Yahoo! Finance]
Elevance Health, Inc. (ELV)
Company Research
Source: Yahoo! Finance
Medicaid margins are nearing a trough and are set to recover over the next several years. BofA raised Elevance Health to Buy from Neutral with a price objective of $435, while moving Centene to Buy from Underperform, with the price objective jumping from $34 to $60. Centene shares rose more than 3% in premarket trading. State Medicaid reimbursement rates have lagged behind actual cost trends since the dramatic shifts in Medicaid enrollment beginning in 2023, squeezing margins across the managed care industry. BofA now believes those margins are bottoming in 2026 and that a multi-year recovery is essentially “a matter of time and math.” For Centene, BofA estimates the company is operating near breakeven in Medicaid, roughly 3% below its long-term target of 2-4% margins, which represents "a ~$4 (~124%) drag to 2026 EPS." Analysts led by Kevin Fischbeck see normalized earnings power of around $12 per share, compared to its 2026 estimate of $3.40, meaning Centene is currently
Show less
Read more
Impact Snapshot
Event Time:
ELV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ELV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ELV alerts
High impacting Elevance Health, Inc. news events
Weekly update
A roundup of the hottest topics
ELV
News
- Elevance Health and 2 More Stocks to Buy. Better Days Are Ahead for Medicaid Providers. [Barron's]Barrons
- Cigna Earnings: What To Look For From CI [Yahoo! Finance]Yahoo! Finance
- Elevance Health (ELV) was upgraded by Citigroup Inc. to "buy".MarketBeat
- Elevance Health (ELV) was upgraded by Bank of America Corporation from "neutral" to "buy". They now have a $435.00 price target on the stock.MarketBeat
- Why agilon health (AGL) Stock Is Up Today [Yahoo! Finance]Yahoo! Finance
ELV
Earnings
- 4/22/26 - Beat
ELV
Sec Filings
- 4/29/26 - Form SCHEDULE
- 4/22/26 - Form 10-Q
- 4/22/26 - Form 8-K
- ELV's page on the SEC website